Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Alternative Healthcare Webinars & Conferences

Europe & UK

Asia Pacific & Middle East


Lifescience Congress 2023

About Conference

We are delighted to invite the researchers & experts from the arena of Healthcare Management; to attend upcoming “4th World Congress on Healthcare & Life-Science Research” is going to be held during October 04-05, 2023 Rome, ItalyLifescience congress 2023 is a specially designed cluster conference which consists of keynote presentations, Oral talks, Poster presentations, Workshops, Panel Discussions and Exhibitions, Young Researcher Forums (YRF).

Lifescience congress 2023  will create platform for health professionals, researchers, scientists, academicians, clinicians and business professionals across the globe to present their latest research, new technologies their knowledge through mutual interaction and exchange of ideas in different destinations around the world. Healthcare administrators focus on managing staff needs, and healthcare managers focus on the broader business aspects of a medical facility.

Why to attend???

Lifescience congress 2023 Conference brings together people from all different geographical areas who share a common field or discipline.

1) To meet with likeminded people and industry peers and they are a great way to meet new people in your field.

2) As you build your professional network, conferences can become a good place for meeting with people in your field that you haven’t connected in a while.

3) Conference gives opportunity to talk to these people one-on-one about what they are working on.

4) To foster discussions, share expertise and exchange knowledge and best practices at all levels of the healthcare spectrum.

5) To showcase new healthcare technologies and solutions in an intimate setting focused specifically on Healthcare.

2022 Highlights:

  • 100+ Participation (70 Industry, 30 Academics)
  • 5+ Keynote Speakers
  • 30+ Plenary Speakers
  • 15+ Exhibitors
  • 5+ Workshops


Intended Audience:  

  • Healthcare providers
  • Healthcare professionals
  • Data Analyst
  • Healthcare Consulting firms
  • Healthcare Investors
  • Healthcare specialists
  • Healthcare Workers
  • Healthcare technology companies
  • Healthcare Societies /NGO’s
  • Healthcare Organizations
  • Healthcare Management Specialists
  • Public Health Professionals
  • Medical Lab Technicians
  • Community Health Workers
  • Foundation Leaders
  • Direct Service Providers
  • Policymakers
  • Researchers
  • Academicians
  • Advocates Policy Makers and others


Scope & Importance:

Health care is the maintenance of health the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in human beings. Health care is the delivered by health professionals in allied health professions, chiropractic, physicians, physician associates, dentistry, nursing, medicine, optometry, pharmacy, psychology, and other health professions. It incorporates the work done in giving essential care, optional care, and tertiary care, and also in general public health. Health Technology is characterized as the use of composed information and abilities as pharmaceuticals, antibodies, strategies and frameworks created to take care of a health issue and enhance nature of lives. It is the incorporate the pharmaceuticals, methodology and hierarchical frameworks utilized as a part of medicinal services. The healthcare industry is the developing at a quick pace and experiencing some of its most noteworthy changes as the utilization of electronic health records increment.

Tracks/ Sessions

1. Healthcare Management

Management of healthcare often referred to as Healthcare Control, Healthcare System Administration, Public Health Services, and entire hospital networks or other  potential medical facilities.Duties of these professionals are like individual departments run properly, qualified employees are recruited, information is disseminated efficiently throughout the company, specific outcomes are reached and resources are used efficiently, among many other duties.

2. Public Healthcare

Public health is the science of protecting and improving the health of public through education, policy making, and research for disease and injury safety. Community healthcare is one of the categories in public health which focuses on people and their role as determinants of people’s health and their own health in contrast to environmental health which focuses on the physical atmosphere and its impact on people’s healthcare.

3. Primary Healthcare

Primary Healthcare defined as healthcare provided in the group of people making a first approach to a doctor or clinic for advice or treatment. Primary health care is whole-of-society proceeds towards to health and well-being centered on the needs and preferences of individuals, families and communities.  It addresses the wide determinants of health and focuses on the comprehensive and interrelated aspects of physical, mental health.

4. Cardiac Healthcare

Cardiac Healthcare is a branch of medicine dealing with Problems of the circulatory systems of the body and Heart. Cardiac Healthcare includes Health diagnosis and therapy of congenital heart defects, coronary artery problems, electrocardiography, vascular heart Problems and heart failure. Physicians who specify in this area of Heart are called cardiologists. Child cardiologists are pediatricians who specialize in cardiology. Physicians who specialize in cardiac surgery are called cardio thoracic surgeons or cardiac surgeons, a specialty of general surgery.

5. Women’s Health & Gynecology

Gynecology is the studies of the female reproductive system. Obstetrics is one of the categories of medicine that focuses on women during pregnancy, childbirth, and the postpartum period. Gynecology is a wider field, focusing on the general health of women and treating conditions that affect the female reproductive systems. For example, women may be referred as gynecologists in the earlier stages of pregnancy, and obstetricians later in their term.

6. Nursing Education

Nursing education center on educating people about strong ways to deliver the healthcare to patients. It teaches nurses about how to administer different medicines, to examine patient and to deliver good services to patients. The aim of nursing education is improvement in the profession of Nursing.

7. Pediatric Healthcare

Pediatrics Healthcare is the branch of medicine dealing with the medical care and health of infants, children, and adolescents from birth up to the age of 18. The word “pediatrics” means “healer of children”. Pediatricians diagnose and treat several health conditions among children including injuries, infections, genetic and congenital conditions and Cancer etc.

8. Healthcare and Nursing

Healthcare nurses work in extend were sharing the qualities is the piece of first level contact with the health framework. Nursing is the Protection, advancement, and improvement of health and capacities, anticipation of sickness and damage, help of mending, mitigation of anguish through the analysis and treatment of human reaction, and support under the watchful eye of people, families, gatherings, groups, and populaces. The fundamental part of nursing experts is to give primary and specialty healthcare services benefits alongside directing patient history and physical examination.

•              Plan of care and Implementation of Treatment

•              Ensuring the Quality of Healthcare

•              Primary Health Promotion and Protection

•              Diagnosis of Health Status


9. Healthcare and Pharmaceuticals

Pharmaceuticals are a reasoning of training in which the patient is the essential recipient of the drug specialist's activities. Pharmaceutical healthcare centres the dispositions, practices, duties, concerns, morals, capacities, learning, obligations and aptitudes of the drug specialist on the arrangement of medication treatment with the objective of accomplishing therapeutic restorative results toward patient health and personal satisfaction. this definition concentrates on drug therapy in the individual patient, the Group extended the recipient of pharmaceutical care to people in general all in all and furthermore to perceive the drug specialist as a medicinal services supplier who can effectively take an interest in sickness counteractive action and health advancement alongside different individuals from the healthcare community

The pharmaceutical business finds, develops, produces, and markets medications or pharmaceutical medications for use as medicines. Pharmaceutical organizations may deal in nonspecific or brand medicines and restorative gadgets. They are liable to an assortment of laws and controls that administer the protecting, testing, security, adequacy and showcasing of medications.

10. Healthcare and Diabetes

Diabetes has turned out to be progressively pervasive; more care is being conveyed and overseen by training medical nurses. It is a disease in which the body’s potential to induce or respond to the hormone insulin is disabled producing in abnormal metabolism of carbohydrates and raised levels of glucose in the urine and blood. The parts of specialists and medical care takers have changed. Consistent diabetes survey is related with enhanced glycaemic control, and amid the most recent decade glycaemic control over the practices has made improved. Rehearses that made more utilization of medical care takers decreased the measure of time patients went through with primary care specialists additionally conveyed more care by and large with proportionate results. The investment funds in specialists’ chance do not have all the assign of being counterbalanced by the extra expenses of time went through with different professionals, transcendently healthcare Workers.

11. Health and Nutrition

Nutrition can be categorized as the science which deals with food & it is directly or indirectly related to health. Public Health Nutrition is a significant inclination for people around the world. Nutrition & Wellness depends upon food, care, fitness and atmosphere. Malnutrition is a condition of nutrition in which a person is not eating the diet with sufficient nutrients required for the body. Food safety and Community nutrition is of prime importance as intake of unhealthy diet along with nutritional deficiencies are the major causes of the food borne diseases & deaths.

12. Psychiatric and mental Healthcare

High inescapability of mental and energetic issue universally will drive the business area of psychiatric medications. WHO ( Word Health Organization) communicated that pretty almost 350 million masses is encountering debilitation and mental issue and around 24 million people extensively is affected by schizophrenia issue. Thusly, rising rates of mental afflictions will at last form the enthusiasm of psychiatric treatment and consequently sustains the business improvement.

The subject of the passionate prosperity pharmaceutical industry is mind boggling and obliges a fitting and promising appraisal of current things and specifically  dosage change designs. The general pharmaceutical business can be studied at $80 billion in 2010. This business is relied on to increment at a 1.9% compound yearly headway rate (CAGR) over the gage time allotment to finish an estimation of $88 billion in 2015.

•              Assessment and evaluation of mental health effects

•              Anxiety and sleep disorders

•              Schizophrenia and nursing care

•              Stress and emotional treatment studies and outcomes

•              Cognitive behavioural therapy and family therapy in nursing

•              Primary mental health care

•              Electroconvulsive therapy and effects


13. Healthcare and Biotechnology

Biotechnology is the wide territory of science including living frameworks and life forms to create or make items, or "any mechanical application that utilizations natural frameworks, living creatures, or subsidiaries thereof, to make or alter items or procedures for particular utilize. Contingent upon the devices and applications, it frequently covers with the (related) fields of molecular biology, bio manufacturing, molecular engineering, bio-engineering, biomedical engineering and so forth.

The wide idea of "biotech" or "biotechnology" incorporates an extensive variety of methodology for adjusting living beings as indicated by human purposes, returning to training of creatures, development of the plants, and "upgrades" to these through reproducing programs that utilize counterfeit determination and hybridization. Present day use incorporates genetic engineering and additionally cell and tissue culture technologies.

Biotechnology is the innovative work in the research centre utilizing bioinformatics for investigation, extraction, misuse and generation from any living creatures and any wellspring of biomass by methods for biochemical designing where high esteem included items could be arranged, determined, detailed, created, made, and promoted with the end goal of maintainable and increasing durable patents licenses

14. Healthcare and Pathology

Pathology is study of disease. Pathology has been characterized as "that branch of solution which treats of the basic idea of Disease." "pathology" originates from the Greek words ''pathos" meaning "disease" and "logos" meaning "a treatise" means a treatise of disease. A restorative specialist that has practical experience in pathology is known as a pathologist. Pathologists are specialists at interpreting microscopic views of body tissues. Pathology is a branch of medicinal science principally concerning the reason, starting point and nature of sickness. It includes the examination of tissues, organs, natural liquids and post-mortem examinations so as to think about and analyse diseases.

Right now, pathology can be separated into eight principle regions, contingent upon the sorts of techniques utilized or the kinds of diseases inspected. These distinctive orders are described below.

•              General pathology

•              Anatomical pathology

•              Clinical pathology

•              Chemical Pathology or Biochemistry

•              Genetics

•              Haematology

•              Immunology

•              Microbiology

Market analysis

Life Science Tools Market Size, Share & Trends Analysis Report By Technology (Cell Biology, Proteomics), By Product, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global life science tools market size was valued at USD 128.15 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.95% from 2022 to 2030. The growth in revenue is mainly due to rapid advancements by the life science tools companies in sequencing, MS, chromatography, NMR, and other various products. Moreover, investments and funding for the development of advanced therapeutics along with continuous demand for novel medicine and treatments due to rising incidence of diseases such as cancer, kidney and thyroid disorders, and diabetes will drive the market.


The COVID-19 pandemic has impacted several industries and the associated supply chains across the globe. This is due to disruption in the supply of key materials such as scarcity of raw materials and labor. In addition, the transportation of raw materials across regions had been put on hold. These factors have led to a shortage of medical supplies, such as molecular and immunoassay kits, digital solutions, life-support machines, and drugs in different regions of the globe. Besides this, the pandemic had a positive impact on the market as the race for developing rapid diagnostics for the SARS-CoV-2 virus led manufacturers to provide innovative breakthroughs. Some of these tests detect the SARS-CoV-2 nucleic material using the PCR technique or via nucleic acid hybridization-related methods or while others are serological and immunological assays that detect antibodies produced in response to the virus. For example, in December 2021, Siemens Healthineers received Emergency Use Authorization from the U.S. FDA for its COVID-19 rapid test, CLINITEST Rapid COVID-19 Antigen Self-Test that can be used for self-testing by individuals aged 14 and above. The pandemic-related new developments, government funding, product approvals, and continuous launches will drive the market.

The growth of gene and cell therapies and their rising demand is anticipated to boost market growth. With the growing demand for robust disease treatment therapies, companies have focused their efforts to accelerate their R&D for effective gene therapies that target the cause of disease at the genomic level. With a rise in the number of FDA-approved products, a healthy outlook for gene therapies is expected in the near future. In addition, advancements in recombinant DNA technology are expected to expand the number of ongoing clinical trials for gene therapy. For instance, in 2020, FDA expected more than 200 applications annually for cell and gene therapy clinical trials by 2029.

The increased understanding of drug interaction with the genetic makeup of patients has led to improvements in targeted therapies. The life science industry is now capitalizing on novel innovations such as predictive analytics to enhance the manufacturing of biological therapeutics to meet the growing demand. This combined with low-cost and robust genetic profiling will improve treatment outcomes and help reduce the drug development cost. The rise in demand for biologics is expected to propel market growth as most biologics are manufactured with the help of recombinant DNA technology. Furthermore, monoclonal antibodies are rapidly evolving in the field of cancer therapy. For instance, according to an article published in January 2021, by mAbxience, 27 monoclonal antibodies have been approved for treating different types of cancer. Moreover, FDA approvals of monoclonal antibodies in diagnostics and cancer therapy are increasing the applications of biologics. For instance, in January 2022, FDA approved Tebentafusp-tebn monoclonal antibody that aids in the treatment of metastatic uveal melanoma. Government support coupled with rising demand for novel therapeutics will boost the growth of the market.

Technology Insights

In 2021, cell biology technology accounted for the largest share of over 30.0%. The relevance of cell biology technology in drug discovery and the increase in NIH funding for cell biology are contributing to segment growth. Additionally, innovations in flow cytometry and liquid handling have led to an upsurge in the applications of cell-based assays for drug discovery. Furthermore, key market players have undertaken collaborative research efforts to reprogram newborn stem cells from umbilical cord tissue and blood into Induced Pluripotent Stem Cells (iPSCs). For example, in January 2022, EdiGene and Haihe Laboratory announced a strategic collaboration to develop platform technologies and stem cell regenerative therapies. The collaboration aims to explore novel biomarkers to optimize quality control for stem cell production. These collaborations are expected to drive the market over the forecast period.

The proteomics technology segment is expected to grow at a significant rate over the forecast period. Proteomics provides a complete understanding of structural and functional information of cells and this technology has allowed a comprehensive study of different types of proteins. This, in turn, helps in the analysis of a cell’s response to a variety of foreign bodies, including drugs. Identification of posttranslational modification has improved due to the development of high-resolution and high-mass accuracy mass spectrometers such as time-of-flight (TOF) mass analyzers. For example, in June 2022, Bruker Corporation announced the launch of timsHOF HT with an enhanced range and aims to revolutionize 4D proteomics and epiproteomics.

Report Coverage & Deliverables

  • Competitive benchmarking
  • Historical data & forecasts
  • Company revenue shares
  • Regional opportunities
  • Latest trends & dynamics

Product Insights

In 2021, cell culture systems and 3D cell culture segment held the largest share of over 15.0%. Research activities exploring the potential of cell biology have led to important advancements, thus contributing to revenue generation. An in-depth understanding of cell biology has become a key asset across laboratory workflows, opening new avenues of expansion in the market. Moreover, scientists in the life science field are eager to adopt new and advanced instruments, which is expected to further bolster the segment. This industry trend has also encouraged several key manufacturers to expand their instrument portfolios. For instance, Cytiva, BioTek Instruments, Horizon Discovery, and Seahorse Bioscience, among others, are aiming on introducing instruments relating to cell analysis, cell biology, and imaging.

Next-generation sequencing is anticipated to exhibit the fastest growth rate of 7.95% from 2022 to 2030. NGS systems allow massively parallel sequencing of genome samples. The systems are efficient in analyzing a large number of sequencing reactions simultaneously. In addition, simplification of NGS workflow and continued cost reductions in instruments and reagents are likely to boost the adoption of this life science technology. Moreover, with enhancement in bioinformatics, adoption of NGS is likely to grow in high- and even low-throughput research. For example, in February 2022, Beckman Coulter Life Sciences signed an application development agreement with Illumina, Inc. for the Biomek NGeniuS Next Generation Library Preparation System.

End-use Insights

The healthcare segment captured the largest share of over 30.0% in 2021. Rise in adoption of proteomic and genomic workflows in hospitals to diagnose and treat various diseases is expected to fuel the growth. In addition, growing adoption of tissue diagnostic and NGS services in hospitals is expected to drive the market. Several hospitals and clinics are currently providing sequencing facilities to patients and are determining the use of advanced tools and technology in daily practice of medicine. Stanford Medicine is one such hospital that provides sequencing services to people who have a rare or undiagnosed genetic condition. Partners HealthCare in the U.S. is one of the first hospital systems to offer public genomic sequencing, analysis, and interpretation services. Genomic sequencing in a hospital or clinical setting is expected to improve patient care while lowering healthcare costs. Due to this, the healthcare segment is expected to witness the fastest growth in the years to come.


Biopharmaceutical companies are initiating large-sale genome sequencing projects in collaboration with community health systems and academic medical centers in the life science tools space. Grail, Inc., an emerging firm, is conducting studies to detect genomic fingerprints from tumors that can be detected in a blood sample, with an aim to identify cancer at an early stage. The growing interest of biopharmaceutical companies in genomics also results in significant revenue generation and thus is expected to drive the market.

Regional Insights

North America accounted for a dominant revenue share of over 35.0% in 2021 due to fast adoption of genomics, proteomics, oncology, and diagnostic screening in the region. The rise in the adoption of genomic medicine, biopharmaceuticals, diagnostic procedures, and novel technologies in the U.S. and Canada for diagnosis and treatment of clinical disorders is responsible for the market growth in the region.  The region also leverages the presence of a large number of market players that are continuously engaged in the development of advanced tools for life science research. Furthermore, the presence of a well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is expected to propel the growth of the market over the forecast period. Recently, in August 2021, COVID-19 Severity Test Screening using Agilent Cary 630 FTIR Spectrometer was launched by Agilent Technologies, In


The Asia Pacific region will grow at the highest rate during the projected period. Investments and efforts by global companies in this region to utilize the untapped avenues and increase their presence will fuel the growth.  For instance, in January 2022, FUJIFILM Corporation announced the acquisition of Atara Biotherapeutics T-Cell Operations and Manufacturing (ATOM) facility for USD 100 million to produce commercial and clinical treatments, including CAR-T and T-cell immunotherapies. Moreover, this region offers relatively inexpensive manufacturing and operating unit for conducting research. These factors are expected to play a major role in the expansion of life science tools and technologies in this region.

Key Companies & Market Share Insights

The market is highly competitive due to the presence of multiple players with similar product offerings. These players are continuously expanding product portfolios and launching new platforms with intensive R&D to sustain market position. Furthermore, strategic initiatives by major firms including collaborations, mergers and acquisitions, and new product launches are fueling the market growth along with intensifying the competition. For instance, in February 2022, Agilent Technologies, Inc. partnered with Biosciences, Inc. to integrate the AVITI System with SureSelect target enrichment panels for enhanced customer access to genomic tools. The initiative was expected to create new growth opportunities for the company. Some prominent players in the global life science tools market include:

Agilent Technologies, Inc.

Becton, Dickinson and Company

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Danaher Corporation

Illumina, Inc.

Thermo Fisher Scientific, Inc.


Merck KGaA

Shimadzu Corporation

Hitachi, Ltd.

Bruker Corporation

Oxford Instruments plc

Zeiss International

Life Science Tools Market Report Scope

Report Attribute


Market size value in 2022

USD 144.95 billion

Revenue forecast in 2030

USD 248.05 billion

Growth rate

CAGR of 6.95% from 2022 to 2030

Base year for estimation


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Technology, product, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; Japan; China;  India; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

Agilent Technologies, Inc.; Becton; Dickinson and Company; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories, Inc.; Danaher Corporation; Illumina, Inc.; Thermo Fisher Scientific, Inc; QIAGEN N.V.; Merck KGaA; Shimadzu Corporation; Hitachi Ltd.; Bruker Corporation; Oxford Instruments plc; Zeiss International

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.


Global Life Science Tools Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global life science tools market report on the basis of technology, product, end-use, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Genomic Technology

Proteomics Technology

Cell Biology Technology

Other Analytical & Sample Preparation Technology

Lab Supplies & Technologies

Product Outlook (Revenue, USD Million, 2018 - 2030)

Cell Culture Systems & 3D Cell Culture

  • Instruments
  • Consumables
  • Cell & Tissue Culture Services

Liquid Chromatography

  • Instruments
  • Consumables
  • Services
  • Mass Spectrometry
  • Instruments
  • Consumables
  • Services
  • Flow Cytometry
  • Instruments
  • Consumables
  • Services
  • Cloning & Genome Engineering
  • Kits, Reagents, and Consumables
  • Service

Microscopy & Electron Microscopy

  • Instruments
  • Consumables
  • Services
  • Next Generation Sequencing
  • Instruments
  • Consumables
  • Services
  • PCR & qPCR
  • Instruments
  • Consumables
  • Services
  • Nucleic Acid Preparation
  • Instruments
  • ConsumablesServices

Nucleic Acid Microarray

  • Instruments
  • Consumables
  • Services

Sanger Sequencing

  • Instruments
  • Consumables
  • Services

Transfection Devices & Gene Delivery Technologies

  • Equipment
  • Reagents


  • Instruments
  • Consumables
  • Services

Other Separation Technologies

  • Instruments
  • Consumables
  • Services

Other Products & Services

  • Antibodies
  • General Supplies
  • Others
  • Instruments
  • Consumables
  • Services

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Government & Academic
  • Biopharmaceutical Company
  • Healthcare
  • Industrial Applications
  • Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

  • U.S.
  • Canada


  • Germany
  • U.K.

Asia Pacific

  • Japan
  • China
  • India

Latin America

  • Brazil
  • Mexico


  • South Africa
  • Saudi Arabia

To Collaborate Scientific Professionals around the World

Conference Date October 04-05, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by